# Neuphoria Therapeutics Inc.: Form DEF 14A, filed Sep 18, 2026

- Company: [Neuphoria Therapeutics Inc.](/companies/neup.md) (CIK 1191070)
- Form: DEF 14A
- Filed: 2026-09-18
- Accepted by EDGAR: Sep 18, 2026, 20:33 ET
- Period: 2026-11-02
- Accession: 0001140361-26-037139
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1191070/000114036126037139/ny20081637x1_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1191070/000114036126037139/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1191070/000114036126037139/ny20081637x1_def14a.htm

Filed Sep 18, 2026.
Source: SEC EDGAR, the filing index for accession 0001140361-26-037139. Last ingested by Listed: Oct 24, 2026, 15:10 ET. No prices; not investment advice.
